HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation.

Abstract
We examined a large French family with autosomal dominant cerebellar ataxia (ADCA) that was excluded from all previously identified spinocerebellar ataxia genes and loci. The patients-seven women and a 4-year-old boy-exhibited slowly progressive childhood-onset cerebellar gait ataxia associated with cerebellar dysarthria, moderate mental retardation (IQ 62-76), and mild developmental delays in motor acquisition. Nystagmus and pyramidal signs were also observed in some cases. This unique association of clinical features clearly distinguishes this new entity from other previously described ADCA. Cerebral magnetic-resonance imaging showed moderate cerebellar and pontine atrophy in two patients. We performed a genomewide search and found significant evidence for linkage to chromosome 19q13.3-q13.4, in an approximately 8-cM interval between markers D19S219 and D19S553.
AuthorsA Herman-Bert, G Stevanin, J C Netter, O Rascol, D Brassat, P Calvas, A Camuzat, Q Yuan, M Schalling, A Dürr, A Brice
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 67 Issue 1 Pg. 229-35 (Jul 2000) ISSN: 0002-9297 [Print] United States
PMID10820125 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Genetic Markers
Topics
  • Adult
  • Age of Onset
  • Child, Preschool
  • Chromosome Mapping
  • Chromosomes, Human, Pair 19 (genetics)
  • Female
  • France
  • Genes, Dominant (genetics)
  • Genetic Markers (genetics)
  • Humans
  • Intellectual Disability (complications, epidemiology, genetics, physiopathology)
  • Lod Score
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pedigree
  • Spinocerebellar Ataxias (complications, epidemiology, genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: